Novo Nordisk Malta Medications and Devices available for Pharmacies
Insulins ACTRAPID HM 100 VIALS NOVORAPID PENFILL 3ml x 5 INSULATARD HM 100 VIALS INSULATARD HM PENFILL 3ml x 5 MIXTARD HM100 VIALS TRESIBA FLEXTOUCH 100U/ML 5 x 3ml (NEW) Needles and Devices NOVOFINE NEEDLES 30g 0.3x8mm x 100 NOVOFINE NEEDLES 31g 0.25x6mm x 100…
Tresiba® (insulin degludec): Lower risk of nocturnal hypoglycaemia vs. insulin glargine
New Tresiba® Summary of Product Characteristics: European Commission approves the label expansion to include children with type 1 and type 2 diabetes
In December 2014 Novo Nordisk announced that the Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for expanded use of Tresiba® (insulin degludec) in children and adolescents aged 1-17 years with diabetes. And now, after the approval of the European…
Tresiba (Insulin Degludec): Flexibility in day-to-day dosing time when needed
Poor glucose control in patients with diabetes can ultimately result in diabetic complications that can bedevastating for the patient’s quality of life, life-shortening, and expensive to treat for national healthcare systems.Current expert guidelines on the treatment of type 2 diabetes therefore advocate the addition of…